胰腺癌和肉症:对当前状况的叙述性回顾
Mariko Tsukagoshi1, Kenichiro Araki1, Ken Shirabe2
1Division of Hepatobiliary and Pancreatic Surgery, Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi Gunma, 371-8511, Japan.
International journal of clinical oncology
|July 2, 2024
概括
肉,或肌肉损失,影响40%的胰腺癌患者. 虽然往往与糟糕的结果有关,但其对预后和治疗并发症的影响仍在争论中,需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 医疗成像医学成像
背景情况:
- 胰腺癌带来了治疗挑战,特别是在老年人群中.
- 标志着肌肉质量和力量损失的萨尔科佩尼亚,影响大约40%的胰腺癌患者.
- 目前对肉类的诊断方法包括成像,人工智能和生物标志物的进展正在进行中.
研究的目的:
- 为了研究在胰腺癌中萨尔科佩尼亚的预后意义.
- 探讨萨尔科佩尼亚与治疗结果之间的关联,包括手术并发症和化疗毒性.
- 为了检查在胰腺癌中萨尔科佩尼亚和免疫功能之间的关系.
主要方法:
- 审查现有的文学和对胰腺癌中肉症的元分析.
- 对诊断方法的分析,包括成像,人工智能和生物标志物.
- 探索研究,检查萨科佩尼亚与预后,手术结果,化疗毒性和免疫力的联系.
主要成果:
- 在胰腺癌患者中,肉症在40%的人群中普遍存在.
- 萨科佩尼亚和不良预后之间的联系仍在争论中,可能取决于癌症的切除能力和治疗类型.
- 目前的证据表明,sarcopenia与术后并发症的增加无关,但其在化疗毒性中的作用尚不清楚.
结论:
- 软骨症是胰腺癌患者常见的病症,具有复杂而有争议的预后作用.
- 需要进一步的研究,以澄清萨科佩尼亚对治疗结果的影响,包括化疗毒性和免疫反应.
- 标准化诊断标准和对潜在机制的进一步调查至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342


